TS169663817	food 10 14	food
TS49663817	drugEffect 22 37	bioavailability
TS149663817	food 223 227	food
TS229663817	mealTime 492 497;512 521	after breakfast
TS79663817	mealTime 546 569	after an overnight fast
TS69663817	mealTime 621 634	fasting state
TS29663817	mealTime 659 674	after breakfast
TS19663817	mealTime 690 699	breakfast
TS199663817	mealTime 745 758	fasting state
TS189663817	mealTime 779 792	fasting state
TS59663817	food 827 831	food
TS89663817	mealTime 958 965	fasting
TS119663817	mealTime 982 985	fed
TS99663817	mealTime 1030 1037	fasting
TS129663817	mealTime 1053 1056	fed
TS109663817	mealTime 1103 1110	fasting
TS139663817	mealTime 1127 1130	fed
TS159663817	food 1208 1212	food
TS239663817	food 1577 1581	food
T1	drug 41 56	triclabendazole
T2	treatedDisease 74 86	fascioliasis
T3	drug 139 154	triclabendazole
T4	drug 157 161	TCBZ
T5	mealTime 177 191	postprandially
R2	increase_absorption Arg1:T5 Arg2:T3	
T6	drug 255 259	TCBZ
T7	drug 275 297;324 335	sulphoxide ( TCBZ-SO ) metabolites
T8	drug 302 335	sulphone ( TCBZ-SO2 ) metabolites
R1	relation Arg1:TS149663817 Arg2:T6	
R3	relation Arg1:TS149663817 Arg2:T7	
R4	relation Arg1:TS149663817 Arg2:T8	
T9	food 500 521	high energy breakfast
T10	numbers 582 584	10
T11	food 679 699	low energy breakfast
T12	drug 903 907	TCBZ
T13	drug 910 917	TCBZ-SO
T14	drug 922 930	TCBZ-SO2
T15	drug 951 955	TCBZ
T16	drug 1020 1027	TCBZ-SO
T17	drug 1092 1100	TCBZ-SO2
T18	drug 1257 1285	active sulphoxide metabolite
T19	mealTime 1409 1421	postprandial
T20	drug 1431 1446	triclabendazole
T21	dosage 1449 1457	10 mg kg
T22	drug 1556 1571	triclabendazole
T23	treatedDisease 1649 1661	fascioliasis
T24	treatedDisease 1665 1679	paragonimiasis
R5	treat Arg1:T1 Arg2:T2	
R6	improve_drug_effect Arg1:TS239663817 Arg2:T22	
R7	treat Arg1:T22 Arg2:T23	
R8	treat Arg1:T22 Arg2:T24	
